The role of Cutibacterium acnes in improving the skin’s barrier function.
Madrigal seeks accelerated approval for experimental NASH treatment a week after Intercept rejection
Madrigal Pharmaceuticals kicked off the regulatory review process for its experimental NASH treatment as it pursues the first FDA approval to treat the debilitating and